Vol 33,2024 No.3 | Articles | Chinese Journal of Pharmacoepidemiology

Home Articles Vol 33,2024 No.3

 Contents

Vol 33,2024 No.3

Date of publication: March 15, 2024

 Get cover  Get contents

Comparison of Runzao Zhiyang capsules and loratadine tablets in drug- induced liver injury: a real-world cohort study

LONG Zilin ZHAO Houyu ZHENG Yongqi WANG Lianxin SUN Feng

2024,33(3):241-250

Runzao Zhiyang capsules Loratadine tablets Drug-induced liver injury Real-world study Retrospective cohort study
Details Download Mobile
Analysis of 2 642 reports of adverse reactions related to carbapenems and risk signal mining

LI Haiyan GUO Daihong YUAN Yonghua ZHU Man GAO Ao LU Jingchuan FU An LI Chao LI Peng ZHAO Anqi

2024,33(3):251-258

Carbapenems Antibacterial drugs Adverse drug reactions Data mining Retrospective analysis
Details Download Mobile
Mining and analysis of busulfan adverse drug events signals based on FAERS database

WANG Guangfei ZHANG Junqi HUANG Yidie WANG Yueyue ZHAI Xiaowen LI Zhiping

2024,33(3):259-268

Busulfan FAERS database Adverse drug event Signal mining Pharmacovigilance
Details Download Mobile
Cost-effectiveness analysis of enzalutamide in the treatment of metastatic prostate cancer

YANG Lei WANG Fengling HUANG Ling LI Yan ZHENG Hanrui ZHENG Lingli CHEN Li

2024,33(3):269-276

Enzalutamide Metastatic prostate cancer Markov model Cost-effectiveness analysis
Details Download Mobile
Pharmacoeconomic study of Bailing capsules plus conventional therapy in treating diabetic kidney disease

HE Yumei LI Wei ZHU He HAN Sheng

2024,33(3):277-290

Bailing capsules Diabetic kidney disease Meta-analysis Cost- effectiveness analysis Pharmacoeconomics
Details Download Mobile
Analysis of current situation of cognition of high-alert medications among medical staffs in Chongming District of Shanghai

SHEN Xian YU Xingxing GU Liuhua YU Kunpeng JIANG Yunda

2024,33(3):291-300

High-alert medications Medical staffs Cognitive status Improvement countermeasure
Details Download Mobile
Efficacy and safety of Chinese patent medicine in the treatment of benign prostatic hyperplasia: a Bayesian network Meta-analysis

MA Jia XING Jianyue ZHANG Yupeng LIU Guangzhen

2024,33(3):301-318

Chinese patent medicine Benign prostate hyperplasia Bayesian network Meta-analysis Randomized controlled trial
Details Download Mobile
Effectiveness of oral probiotics for hepatectomised patients: a Meta- analysis

GONG Caifang Xiong Yongfu ZHAO Junyu YOU Chuan

2024,33(3):319-329

Probiotics Hepatic resection Infection Meta-analysis Systematic review Randomized controlled trial
Details Download Mobile
Efficacy and safety of hydroxychloroquine in the treatment of obstetric antiphospholipid syndrome: a Meta-analysis

ZHANG Xuepei TANG Xiuneng LI Na LIAO Shasha LIU Yunyuan HE Guanlan ZHANG Hongliang

2024,33(3):330-341

Hydroxychloroquine Obstetric antiphospholipid syndrome Live birth rate Meta-analysis
Details Download Mobile